Gentian Diagnostics AS

NEW
OSTO:GENTOo (Norway)  
kr 40 (0%) Aug 14
At Loss
P/B:
3.28
Market Cap:
kr 599.79M ($ 63.61M)
Enterprise V:
kr 537.26M ($ 56.98M)
Volume:
0
Avg Vol (2M):
150.00
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
150.00

Gentian Diagnostics AS’s share price is kr40. Its GF Value is kr53.59. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Gentian Diagnostics AS stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: kr40 GF Value Price/GF Value
Current kr53.59 0.75
Next FY1 End kr57.47 0.70
Next 12 Month kr64.74 0.62
Next FY2 End kr68.39 0.58
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Gentian Diagnostics AS's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The findings reveal that Gentian Diagnostics AS's stock price shows no significant correlation with any of these four metrics.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies